❌

Normal view

Nurse-led urology clinic records 14,013 registrations in descriptive study

21 October 2026 at 23:17

A nurse-led chronic disease management clinic in the urology department of a tertiary hospital recorded 14,013 outpatient registrations between July 2024 and September 2026, according to a single-center retrospective descriptive study using routinely collected service records. The clinic primarily supported long-term management of patients with prostate and bladder cancer while also providing specialty nursing services for other urological conditions. Its follow-up system marked 3,547 of 3,553 assigned tasks as successful, a task-level success rate of 99.83%. These figures describe service activity and record completion; the study did not measure whether the clinic improved clinical outcomes or economic performance.

The clinic was established in July 2024 within the hospital’s existing specialty nursing outpatient service framework. Its operating model included staffing and qualification requirements, professional training, clearly defined nursing responsibilities, physician–nurse collaboration, standardized procedures, information-system support and quality management. Nurses worked within their authorized scope of practice, while urologists participated in medical assessment and treatment decisions when required. The service had four reported components: patient assessment and follow-up planning; treatment follow-up and adverse-event monitoring; rehabilitation guidance and health promotion; and assistance with healthcare policies and basic nursing care.

Monthly registrations increased from 147 in July 2024 to a peak of 710 in August 2026, with fluctuations during the reporting period. Total registration fees were CNY 152,758. The clinic delivered 14,246 prostate cancer-related injections, 3,523 urinary catheterizations, 2,777 intravesical instillation procedures and 2,142 urinary catheter removals. It also assisted patients with prostate or bladder cancer in applying for outpatient chronic and special disease insurance benefits. The study reports these counts as routine service activities, but it did not compare the procedures with those delivered elsewhere or evaluate their individual clinical effects.

Follow-up management was integrated into the clinic’s information system, which contained records for 1,111 patients. Of these, 953 patients had been followed up and 951 had successful follow-up records. Nurses also executed 3,553 follow-up tasks, of which 3,547 were successful, corresponding to the reported 99.83% task-level rate. The descriptive data do not specify the duration or effectiveness of patient follow-up, assess whether missed contacts influenced treatment adherence or health outcomes, or establish how the results would compare with another care model.

Because the research covered one tertiary hospital and relied on routinely collected records, it cannot establish how the clinic would operate in smaller facilities, under different staffing arrangements or in other health systems. The findings offer a documented example of a nurse-led outpatient service with defined responsibilities, standardized workflows, follow-up documentation and collaboration with urologists. The authors stated that further research is needed to evaluate the model’s clinical outcomes and economic implications. Accordingly, the registration growth, procedural workload and high proportion of completed follow-up tasks should be interpreted as descriptions of implementation and recorded service delivery, not as evidence of improved survival, fewer complications, lower costs or other patient benefits.

Subject of Research: Operation and service activity of a nurse-led chronic disease management clinic in hospital urology

Article Title: Development and implementation of a nurse-led chronic disease management clinic in the urology department of a tertiary hospital: a descriptive study

Article References: Liu, C., Xia, Y., Jia, X., Wang, R., Li, T., Ma, Y., & Long, H. (2026). Development and implementation of a nurse-led chronic disease management clinic in the urology department of a tertiary hospital: a descriptive study. BMC Nursing. https://doi.org/10.1186/s12912-026-05566-z

Image Credits: AI Generated

DOI: 10.1186/s12912-026-05566-z

Keywords: nurse-led care, urology, outpatient nursing, chronic disease management, prostate cancer, bladder cancer, patient follow-up, service implementation, descriptive study, Development, implementation, nurse-led

★ HAYLOU Velo combina estilo para o dia a dia, carregamento sem fio e uma grande tela AMOLED

21 October 2026 at 22:53

A HAYLOU anunciou nesta semana o HAYLOU Velo, um novo smartwatch que combina design contemporâneo com recursos práticos para o dia a dia. Com uma estrutura de liga de zinco, carregamento sem fio e duas pulseiras intercambiáveis incluídas na caixa, o Velo oferece uma alternativa versátil para quem deseja um smartwatch que combine com seu estilo pessoal e sua rotina diária.

Uma tela brilhante e um design diferenciado

O Velo conta com uma tela AMOLED de 1,96 polegada, resolução de 410×502 pixels e brilho máximo de até 1.500 nits, trazendo cores vibrantes e detalhes nítidos no pulso, mesmo em condições externos com muita luz.

HAYLOU Velo
Divulgação/HAYLOU

Uma estrutura central de liga de zinco, vidro 2.5D e botões de liga de alumínio conferem ao relógio uma aparência limpa e contemporânea. Disponível nas cores preta e branca, o Velo foi desenhado para combinar com uma série de estilos do dia a dia.

Duas pulseiras, mais maneiras de usar

O Velo vem com duas pulseiras intercambiáveis: uma pulseira texturizada com padrão ondulado (para um visual diferenciado) e uma pulseira de silicone macio (para treinos e dias mais ativos). A troca entre elas permite aos usuários adaptar o relógio a diferentes roupas e ocasiões.

HAYLOU Velo
Divulgação/HAYLOU

A personalização continua na tela, com mais de 200 mostradores disponíveis online, suporte a mostradores personalizados, quatro layouts para o menu principal e cinco estilos visuais.

Recursos inteligentes para a conveniência diária

O Velo mantém os usuários conectados com chamadas via Bluetooth e notificações inteligentes, além de ferramentas úteis, como controles de música e câmera, assistente de voz e localização do celular. Os usuários de Android também podem responder a mensagens do WhatsApp diretamente pelo pulso.

HAYLOU Velo
Divulgação/HAYLOU

Com mais de 100 modos esportivos e monitoramento diário de atividades, o Velo foi construído para acompanhar os movimentos ao longo do dia, desde as atividades da rotina até os treinos.

Carregamento sem fio, menos complicações

O carregamento sem fio torna a recarga do Velo simples e conveniente. Sua bateria de 300mAh oferece até sete dias de uso, dependendo das configurações e do uso.

HAYLOU Velo
Divulgação/HAYLOU

Com classificação de resistência à água de 1ATM, o Velo foi projetado para lidar com respingos cotidianos e chuva leve, mas não é indicado para natação ou banho.

Preço e disponibilidade

O HAYLOU Velo estará disponível nas cores preta e branca por meio dos canais oficiais de venda da HAYLOU e de parceiros varejistas selecionados em todo o mundo. O preço de varejo estimado é de aproximadamente US$45, com o preço final variando de acordo com o mercado, o varejista e o período promocional.

Para mais informações, acesse o site oficial.

Sobre a HAYLOU

A HAYLOU é uma marca global de tecnologia de dispositivos vestíveis inteligentes e áudio, comprometida em tornar a tecnologia cotidiana acessível. Por meio de produtos de áudio inteligente, dispositivos vestíveis e tecnologias práticas de saúde, a HAYLOU cria experiências confiáveis e agradáveis que ajudam as pessoas a levar vidas mais saudáveis, ativas e conectadas.

NOTA DE TRANSPARÊNCIA: O MacMagazine recebe uma pequena comissão sobre vendas concluídas por meio de links deste post, mas você, como consumidor, não paga nada a mais pelos produtos/serviços ao usar os nossos links de afiliado.

MacVoices #26283: Live! – ‘Pro and Tell,’ Duo Delays, Apple at $5 Trillion, and Affinity for iPad

By: Chuck
21 October 2026 at 22:21
Apple’s upcoming “Pro and Tell” event sparks speculation about new MacBook Pro models, while iPhone Duo preorders raise questions about shipping delays and retail availability. The panel discusses Apple’s $5 trillion valuation, why HomeView won’t launch in the European Union, and the anticipated arrival of Affinity Studio on iPad, including how it could transform creative workflows and provide yet another powerful alternative to Adobe Creative Cloud. 

💾

❌